Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06474234
PHASE2
Modulation of Gut Microbiota by Probiotic in Children
Sponsor: Min-Tze LIONG
View on ClinicalTrials.gov
Summary
This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of healthy children, among pre-school children in Malaysia \<7 years old.
Key Details
Gender
All
Age Range
1 Month - 7 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-05-29
Completion Date
2025-06-30
Last Updated
2024-06-25
Healthy Volunteers
Yes
Conditions
Interventions
DIETARY_SUPPLEMENT
Probiotic
Bifidobacterium infantis YLGB-1496 at 1x10 log CFU/day for 12 weeks
DIETARY_SUPPLEMENT
Placebo
Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)
Locations (1)
UKM Medical Centre
Cheras, Kuala Lumpur, Malaysia